Detalhe da pesquisa
1.
Reappraisal of the conventional hemostasis tests as predictors of perioperative bleeding in the era of rebalanced hemostasis in cirrhosis.
Hepatology;
2024 Jan 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38214562
2.
Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver disease.
Hepatology;
2024 Mar 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38470216
3.
A new clinical and prognostic characterization of the patterns of decompensation of cirrhosis.
J Hepatol;
80(4): 603-609, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38110003
4.
Prevalence of HCV infection in Europe in the DAA era: Review.
Liver Int;
2024 May 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38804727
5.
From Prioritization to Universal Treatment: Successes and Challenges of Hepatitis C Virus Elimination in Italy.
J Infect Dis;
228(Suppl 3): S211-S220, 2023 09 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37703346
6.
Metabolic dysfunction outperforms ultrasonographic steatosis to stratify hepatocellular carcinoma risk in patients with advanced hepatitis C cured with direct-acting antivirals.
Liver Int;
43(7): 1593-1603, 2023 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37035867
7.
Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic hepatitis C aged 75 years or older: A multicentre study.
Liver Int;
43(7): 1440-1445, 2023 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37122194
8.
A territory-wide opportunistic, hospital-based HCV screening in the general population from northern Italy: The 1969-1989 birth-cohort.
Liver Int;
43(12): 2645-2656, 2023 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37715524
9.
Incidence of liver- and non-liver-related outcomes in patients with HCV-cirrhosis after SVR.
J Hepatol;
76(2): 302-310, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34592366
10.
Rare ATG7 genetic variants predispose patients to severe fatty liver disease.
J Hepatol;
77(3): 596-606, 2022 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35405176
11.
RESIST-HCV Criteria to Monitor Progression of Low-Risk Esophageal Varices in Patients With Compensated Cirrhosis After HCV Eradication: The SIMPLE Study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices.
Am J Gastroenterol;
117(11): 1816-1824, 2022 11 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35973181
12.
Clinical exome sequencing for diagnosing severe cryptogenic liver disease in adults: A case series.
Liver Int;
42(4): 864-870, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35132767
13.
Implementation of HCV screening in the 1969-1989 birth-cohort undergoing COVID-19 vaccination.
Liver Int;
42(5): 1012-1016, 2022 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35220667
14.
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores.
J Hepatol;
74(4): 775-782, 2021 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33248170
15.
Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients With Clinically Significant Portal Hypertension: Too Rare to Warrant Universal Β-Blocker Therapy.
Am J Gastroenterol;
116(6): 1342-1344, 2021 06 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33606382
16.
A new algorithm shows superior ability to discriminate liver fibrosis stages in chronic hepatitis C.
J Viral Hepat;
28(10): 1443-1451, 2021 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34228858
17.
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting.
J Viral Hepat;
28(3): 558-568, 2021 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33306247
18.
Hepatic Fat-Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAs.
Hepatology;
72(6): 1912-1923, 2020 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32762045
19.
High rates of 30-day mortality in patients with cirrhosis and COVID-19.
J Hepatol;
73(5): 1063-1071, 2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32526252
20.
Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis.
J Hepatol;
73(3): 593-602, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32243959